In a phase 4 trial, dupilumab effectively reduces airway inflammation and mucus plugging, improving lung function and asthma control in patients with moderate to severe type 2 asthma.

Now financially in the black, the food delivery specialist has been making in-roads into other market sectors with automation ...

Migrating legacy code and applications to modern systems is risky and time-consuming, but often unavoidable. Here are seven ...

Dental implants have revolutionized the treatment of missing teeth, providing a reliable and aesthetically pleasing ...

Guinness, like other Irish stouts, enjoys a seasonal popularity every St. Patrick’s Day. It has also been touted as being ...

Men with the best semen quality can expect to live two to three years longer, on average, than men with the lowest semen ...

It took thousands of years to develop the world's extraordinary range of domesticated farm animals—an estimated 8,800 ...

In the market for a new electric range? We've scoured customer reviews to bring you the best options based on features and ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Discover how NASA JPL is pushing additive manufacturing boundaries. Insights from Dr. Ryan T. Watkins await at the AMUG Conference.

42 Technology (42T) has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, ...

NDA submission based on results from Phase 3 DUPLEX and Phase 2 DUET studies of FILSPARI in FSGS If approved, FILSPARI could become the first and only FDA-approved treatment for FSGS, a rare kidney ...